532 related articles for article (PubMed ID: 15191592)
1. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
Buduneli N; Buduneli E; Ciotanar S; Atilla G; Lappin D; Kinane D
J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of p53, bcl-2, and interleukin-15 levels in gingival crevicular fluid of cyclosporin A-treated patients.
Buduneli E; Genel F; Atilla G; Kütükçüler N
J Periodontol; 2003 Apr; 74(4):506-11. PubMed ID: 12747456
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator system in smokers and non-smokers with and without periodontal disease.
Buduneli N; Buduneli E; Kardeşler L; Lappin D; Kinane DF
J Clin Periodontol; 2005 Apr; 32(4):417-24. PubMed ID: 15811061
[TBL] [Abstract][Full Text] [Related]
4. Crevicular fluid interleukin-1beta, tumor necrosis factor-alpha, and interleukin-6 levels in renal transplant patients receiving cyclosporine A.
Atilla G; Kütükçüler N
J Periodontol; 1998 Jul; 69(7):784-90. PubMed ID: 9706856
[TBL] [Abstract][Full Text] [Related]
5. Levels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine A.
Emingil G; Coker I; Atilla G; Hüseyinov A
J Periodontol; 2000 Jan; 71(1):50-7. PubMed ID: 10695938
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of transforming growth factor-beta 1 level in crevicular fluid of cyclosporin A-treated patients.
Buduneli N; Kütükçüler N; Aksu G; Atilla G
J Periodontol; 2001 Apr; 72(4):526-31. PubMed ID: 11338306
[TBL] [Abstract][Full Text] [Related]
7. Gingival crevicular fluid transforming growth factor-beta1 in cyclosporine and tacrolimus treated renal transplant patients without gingival overgrowth.
Gürkan A; Afacan B; Emingil G; Töz H; Başkesen A; Atilla G
Arch Oral Biol; 2008 Aug; 53(8):723-8. PubMed ID: 18342291
[TBL] [Abstract][Full Text] [Related]
8. Gingival crevicular fluid osteocalcin, N-terminal telopeptides, and calprotectin levels in cyclosporin A-induced gingival overgrowth.
Becerik S; Gürkan A; Afacan B; Özgen Öztürk V; Atmaca H; Töz H; Atilla G; Emingil G
J Periodontol; 2011 Oct; 82(10):1490-7. PubMed ID: 21342006
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases (MMP-8 and -9) and neutrophil elastase in gingival crevicular fluid of cyclosporin-treated patients.
Atilla G; Sorsa T; Rönka H; Emingil G
J Periodontol; 2001 Mar; 72(3):354-60. PubMed ID: 11327063
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator (t-PA) and placental plasminogen activator inhibitor (PAI-2) in gingival crevicular fluid from patients with Papillon-Lefèvre syndrome.
Ullbro C; Kinnby B; Lindberg P; Matsson L
J Clin Periodontol; 2004 Sep; 31(9):708-12. PubMed ID: 15312091
[TBL] [Abstract][Full Text] [Related]
11. The plasminogen-activating system in gingival fluid from adults. An intra-individual study before and after treatment of gingivitis.
Kinnby B; Matsson L; Lecander I
Scand J Dent Res; 1994 Dec; 102(6):334-41. PubMed ID: 7871356
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of t-PA, PAI-2, IL-1beta and PGE(2) in gingival crevicular fluid of rheumatoid arthritis patients with periodontal disease.
Biyikoğlu B; Buduneli N; Kardeşler L; Aksu K; Oder G; Kütükçüler N
J Clin Periodontol; 2006 Sep; 33(9):605-11. PubMed ID: 16856901
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of inducible and endothelial forms of nitric oxide synthase in cyclosporin A-induced gingival overgrowth.
Gürkan A; Emingil G; Oktem G; Selvi N; Afacan B; Tunç Ilgenli ; Töz H; Atilla G
J Periodontol; 2009 Oct; 80(10):1638-47. PubMed ID: 19792854
[TBL] [Abstract][Full Text] [Related]
14. Short term effects of non-surgical periodontal treatment on gingival crevicular fluid levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in patients with chronic and aggressive periodontitis.
Tüter G; Ozdemir B; Kurtiş B; Serdar M; Yücel AA; Ayhan E
Arch Oral Biol; 2013 Apr; 58(4):391-6. PubMed ID: 22980426
[TBL] [Abstract][Full Text] [Related]
15. Gingival crevicular fluid PGE2, IL-1beta, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease.
Kardeşler L; Buduneli N; Biyikoğlu B; Cetinkalp S; Kütükçüler N
Clin Biochem; 2008 Jul; 41(10-11):863-8. PubMed ID: 18472001
[TBL] [Abstract][Full Text] [Related]
16. Gingival tissue proteoglycan and chondroitin-4-sulphate levels in cyclosporin A-induced gingival overgrowth and the effects of initial periodontal treatment.
Vardar S; Baylas H; Zihnioğlu F; Buduneli N; Emingil G; Atilla G
J Clin Periodontol; 2005 Jun; 32(6):634-9. PubMed ID: 15882223
[TBL] [Abstract][Full Text] [Related]
17. Detection of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2(PAI-2) in gingival crevicular fluid from healthy, gingivitis and periodontitis patients.
Yin X; Bunn CL; Bartold PM
J Clin Periodontol; 2000 Mar; 27(3):149-56. PubMed ID: 10743860
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 levels in gingival fibroblasts of cyclosporin A-treated patients.
Tüter G; Serdar MA; Yalim M; Gürhan IS; Baloş K
J Periodontol; 2002 Nov; 73(11):1273-8. PubMed ID: 12479630
[TBL] [Abstract][Full Text] [Related]
19. Gingival crevicular fluid and serum matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 levels in renal transplant patients undergoing different immunosuppressive therapy.
Emingil G; Afacan B; Tervahartiala T; Töz H; Atilla G; Sorsa T
J Clin Periodontol; 2008 Mar; 35(3):221-9. PubMed ID: 18269661
[TBL] [Abstract][Full Text] [Related]
20. Effects of menstrual cycle on periodontal health and gingival crevicular fluid markers.
Becerik S; Ozçaka O; Nalbantsoy A; Atilla G; Celec P; Behuliak M; Emingil G
J Periodontol; 2010 May; 81(5):673-81. PubMed ID: 20218781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
